Login to Your Account



Biocom Partnering Conference

Beyond HCV: Pharma Panelists Discuss Licensing Wish Lists

By Trista Morrison
Staff Writer

Tuesday, February 7, 2012
SAN DIEGO – Mere minutes into the recent Biocom Global Life Science Partnering Conference, a panel of big pharma and big biotech business development executives had already launched into a discussion about hepatitis C virus (HCV).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription